These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1521670)

  • 21. The effect of buflomedil in diabetic retinopathy estimated by ocular fluorophotometry.
    Kjaergaard JJ; Ditzel J
    Int J Microcirc Clin Exp; 1987 Aug; 6(3):257-63. PubMed ID: 3308731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of buflomedil in vascular radiology of hepatoma].
    Emery JC; Genin G; Bonvoisin S; Croisille M
    Ann Radiol (Paris); 1994; 37(6):441-8. PubMed ID: 7702337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011.
    Bucolo C; Longo L; Camillieri G; Drago F; Salomone S
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1190-6. PubMed ID: 22855302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V; Mikhailidis DP; Barradas MA; Jeremy JY; Gracey L; Dandona P
    Int J Clin Pharmacol Res; 1988; 8(5):377-81. PubMed ID: 3229875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An experimental overview of a new vasoactive drug: buflomedil HCl.
    Dubourg A; Scamuffa RF
    Angiology; 1981 Oct; 32(10):663-75. PubMed ID: 7034590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of buflomedil on microvascular disorders in diabetic patients.
    Le Dévéhat C; Vimeux M; Bondoux G; Khodabandehlou T
    Blood Vessels; 1991; 28 Suppl 1():38-43. PubMed ID: 1932765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of the ability of the peripheral vasodilator buflomedil to improve vascular patency after acute frostbite.
    Daum PS; Bowers WD; Tejada J; Morehouse D; Hamlet MP
    Cryobiology; 1989 Feb; 26(1):85-92. PubMed ID: 2924596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura].
    Paterna S; Martino S; Ingurgio NC; Arrostuto A; Correo S; Licata G
    Clin Ter; 1994 Apr; 144(4):307-19. PubMed ID: 7911406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microcirculatory changes in patients with primary Raynaud's phenomenon after treatment with buflomedil.
    Jacobs MJ; Lemmens HA
    Int J Microcirc Clin Exp; 1985; 4(1):63-8. PubMed ID: 3886577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of frostbites. Analysis of results in twenty patients with buflomedil chlorhydrate (author's transl)].
    Foray J; Baisse PE; Mont JP; Cahen C
    Sem Hop; 1980 Mar 8-15; 56(9-10):490-7. PubMed ID: 6244676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of buflomedil in a rat model of moderate cerebral ischemia.
    Briguglio FS; Mondello MR; Galluzzo M; Raneri E; De Pasquale A; Saija A; Trombetta D
    Arzneimittelforschung; 2005; 55(8):437-42. PubMed ID: 16149710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
    Chacón-Quevedo A; Eguaras MG; Calleja F; Garcia MA; Roman M; Casares J; Muñoz I; Concha M
    Angiology; 1994 Jul; 45(7):647-53. PubMed ID: 8024164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L; Gandolfo AM; Utz C
    MMW Munch Med Wochenschr; 1984 Mar; 126(9):247-8. PubMed ID: 6425678
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of buflomedil in geriatric patients suffering from vascular cerebral insufficiency.
    Demichelis Genesio MA; Sanz MC
    Angiology; 1981 Oct; 32(10):717-28. PubMed ID: 7034593
    [No Abstract]   [Full Text] [Related]  

  • 35. Dialysis clearance of buflomedil in hemodialysed patients.
    Rey E; Moynot A; d'Athis P; Pello JY; Maurel A; Frydman MO; Buisson C; Olive G
    Arzneimittelforschung; 1996 May; 46(5):492-5. PubMed ID: 8737633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Our experience with the use of buflomedil chlorhydrate in a mixed population of vasculopathic patients.
    Battaglia L; Valgiusti D; Di Paola FM
    J Int Med Res; 1984; 12(2):63-72. PubMed ID: 6724128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J; Intaglietta M; Messmer K
    Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galantamine treatment of vascular dementia: a randomized trial.
    Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
    Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double blind comparative study of cinnarizine and buflomedil in patients suffering from cerebrovascular insufficiency.
    Pacheco e Silva A; Landi de Almedia AM
    Angiology; 1981 Oct; 32(10):728-32. PubMed ID: 7325407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
    De Martiis M; Parenzi A; Barlattani A; De Martiis A
    Clin Ter; 1986 Mar; 116(5):367-71. PubMed ID: 3519061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.